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Abstract
Cancer cells interact with surrounding stromal fibroblasts during tumorigenesis, but the complex molecular rules that
govern these interactions remain poorly understood thus hindering the development of therapeutic strategies to target
cancer stroma. We have taken a mathematical approach to begin defining these rules by performing the first large-scale
quantitative analysis of fibroblast effects on cancer cell proliferation across more than four hundred heterotypic cell line
pairings. Systems-level modeling of this complex dataset using singular value decomposition revealed that normal tissue
fibroblasts variably express at least two functionally distinct activities, one which reflects transcriptional programs
associated with activated mesenchymal cells, that act either coordinately or at cross-purposes to modulate cancer cell
proliferation. These findings suggest that quantitative approaches may prove useful for identifying organizational principles
that govern complex heterotypic cell-cell interactions in cancer and other contexts.
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Introduction
Cancer cells interact dynamically with surrounding stromal
cells. Among the many relevant cell types within cancer stroma,
fibroblasts appear to function prominently [1]. However, we lack a
clear understanding of how molecular and cellular heterogeneity
within this cell type functionally contributes to cancer initiation
and progression [2]. In part, this is due to the experimental
challenges inherent in studying multi-cellular interactions. While
increasingly sophisticated animal models are being used to define
discrete mechanisms by which fibroblasts contribute to tumor
progression, these models are not well-suited for systematic
discovery across multiple genetic and epigenetic contexts [3–6].
An alternative experimental approach involves analyzing the
interaction of dissociated cancer cells and fibroblasts in vitro [7–
11]. This approach has the potential to enable systematic and
unbiased molecular screening for new stromal targets that can
subsequently be validated in more physiologically relevant systems.
In vitro approaches to studying cellular interactions are generally
limited by the choice of specific cells, culture conditions, and assays.
The ideal system would examine functional interactions between
different primary cancer cell and fibroblast populations co-derived
from the same tumors. However, primary human cancer cells are
notoriously difficult to propagate long-term ex vivo, and primary
tumor-derived fibroblasts appear to undergo phenotypic changes in
short-term culture [6]. In contrast, established cell lines are easily
grown, relatively inexpensive, and readily available, thus represent-
ing a potentially useful and renewable resource for studying cancer-
fibroblast interaction. In addition, culture conditions can influence
cellular behavior but increasingly complex approaches that attempt
to mimic physiologically relevant conditions, such as three-
dimensional culture, scale poorly [12]. Finally, fibroblasts affect
many aspects of cancer cell behavior including proliferation and
survival, angiogenesis, invasion, metastasis, and drug resistance, but
assays to score increasingly complex phenotypes can be challenging
to implement in systematic studies.
We therefore performed a quantitative and integrated analysis
using mathematical modeling of cancer cell proliferation in two-
dimensional co-culture with a large number ofnormalfibroblastcell
lines. These studies revealed that normal tissue fibroblasts variably
express at least two functionally distinct activities in modulating
cancer cell proliferation. Furthermore, transcriptional profiling of
these different fibroblast populations revealed that at least one of
these activities might relate to molecular programs that are present
in activated mesenchyme. Systems-level modeling may thus be
useful for identifying organizational principles that broadly underlie
the interactions of cancer cells and fibroblasts, and may therefore
inform systematic molecular studies of cancer-fibroblast interaction.
Materials and Methods
Cell lines and plasmid DNA
Cell lines were purchased from ATCC (Manassas, VA) or
Coriell Cell Repositories (Camden, NJ). All fibroblast lines were
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e6888used for co-cultures within 10 passages after purchase. Cancer and
fibroblast cell lines were cultured in Dulbecco’s Modified Eagle
Medium (DMEM) with 10% fetal calf serum (FCS), L-glutamine
(4 mM), penicillin (100 units/mL), and streptomycin (100 mg/
mL). EGFP labeling of cancer cell lines was done using a third-
generation lentiviral vector system. 293T cells were transfected
using lipofectamine 2000 in a subconfluent 10-cm dish with the
vector pCCLsin.PPT.hPGK (10 mg), into which EGFP had been
cloned, as well as pMDLg/p packaging (7 mg) and VSV-G
envelope encoding pMD.G (5 mg) plasmids. These plasmids were
obtained from Rafaella Sordella at the MGH Center for Cancer
Research and Luigi Naldini at the San Raffaele Telethon Institute
for Gene Therapy. Viral supernatant was collected after 48 hours,
filtered with a 0.45 micron syringe filter, and stored at 280uC.
Cancer cell lines were infected in subconfluent wells of 24-well
plates, using 300 mL of virus in 1 mL of DMEM culture media
with 10% fetal calf serum. This protocol yielded infection rates in
excess of 80% (determined by visual assessment using fluorescence
microscopy). EGFP-negative cells were removed using a modified
5-laser Becton-Dickinson FACSDiVa with standard techniques as
previously described [13].
Quantitative co-cultures
2610
4 fibroblasts were seeded in 100 mL in at least 6 replicate
wells in each of two 96 well plates and allowed to adhere into a
confluent monolayer overnight. Subsequently 10
3 EGFP-express-
ing cancer cells were seeded in an additional 50 mL into the
fibroblast containing wells and into empty wells (150 mL total
volume per well). A Spectramax M5 plate reader (Molecular
Devices, Sunnyvale, CA) was used to obtain fluorescent readings
approximately once daily for 14 days (excitation 477 nm, emission
515 nm). Thirty microliters of fresh media were added to each well
on days 3, 6, 9, and 12. Wells containing fibroblasts or media
alone, all with 150 mL of media per well on day 0, were measured
in parallel and the values subtracted from co-culture and
monoculture wells, respectively, to account for auto-fluorescence.
All cultures were performed in DMEM with 10% FCS.
Heterotypic xenografts: Estradiol pellets (0.72 mg, 60-day release,
Innovative Research of America, Sarasota, FL) were implanted
into female nude mice (Charles River Laboratories) two days prior
to xenograft injections. Mice were divided into 2 groups: 5 mice
were injected with AG09877 fibroblasts and EGFP-expressing
T47D breast cancer cells, and 5 mice were injected with AG04351
fibroblasts and EGFP-expressing T47D cells. Cells were trypsin-
ized and re-suspended in Hank’s Balanced Salt Solution at a
concentration of 4610
6 million cells per 100 microliters. Animals
anesthetized with isoflurane were injected with 4610
6 fibroblasts
and 4610
5 cancer cells into the subcutaneous tissue over the
mammary fat pad. EGFP signal was imaged and quantified using
a bonSAI fluorescence optical imaging system immediately after
injection, daily for four days, and then every 2–3 days. Mice were
treated in compliance with MGH Institutional Animal Care and
Use Committee regulations and sacrificed 43 days after injection.
Tumor tissue was resected and flash frozen. Frozen sections were
stained with hematoxylin and eosin or with anti-cytokeratin (CAM
5.2, Becton-Dickinson).
Data processing
To quantify the effect of fibroblasts on the growth of cancer cells, we
defined the mono-culture curve, mt ðÞ , to be the difference on day t
between the average fluorescence measurement for the wells with
cancer cells but no fibroblasts and the average fluorescence
measurement for the wells with media alone. We defined the co-
culture curve, ct ðÞ , to be the difference on day t between the average
fluorescence measurement for the wells with cancer cells and fibroblasts
and the average fluorescence measurementforthewellswithfibroblasts
alone. We removed constant signal by subtracting the smaller day 0
value. Specifically, we let ~ m mt ðÞ ~mt ðÞ {min m 0 ðÞ ,c 0 ðÞ ðÞ and let
~ c ct ðÞ ~ct ðÞ {min m 0 ðÞ ,c 0 ðÞ ðÞ . Co-culture ratios were defined as the
ratio of the area under these two curves. Specifically, where M is the
area under the ~ m mt ðÞcurve, we let t0,t1,...,tn be the days for which we
have measurements and interpolated linearly between measurement
times. By the trapezoid rule,
M~
X n{1
i~0
1
2
~ m mt i ðÞ z~ m mt iz1 ðÞ ðÞ tiz1{ti ðÞ :
We defined C similarly to be the area under the ~ c ct ðÞcurve. We
then defined the co-culture ratio, E,b y
E~ C=M ðÞ :
To compute confidence intervals (CIs) for E, we used the union
of three bootstrap BCa two-sided 95% CIs, each computed from
10,000 bootstrap samples [14]. The bootstrap samples are formed
by first choosing with replacement from the two replicate 96-wells
plates and by then choosing with replacement wells of each type
(i.e., media-only, fibroblast, mono-culture, co-culture) from the
chosen plates. The co-culture ratio was considered significant if the
95% CI for E was completely above or below one.
Mathematical modeling
We hypothesized that a small number of functionally distinct
interaction types underlie the large number of data points in the
matrix of co-culture ratios. We suspected that if we could
determine an optimal number, N, of simpler matrices with which
to approximate the co-culture ratio matrix, then that optimal N
would give us some idea of the number of functionally distinct
interaction types at work and the matrices that comprise the
approximation might give us some insight into the nature of those
interactions.
A variety of methods exist to decompose a mathematical matrix
into a sum of simpler matrices that are in some sense orthogonal or
independent of one another [15]. Models based on singular value
decomposition (SVD) or principal component analysis (PCA) have
been most widely used across a broad range of biological,
chemical, and physical sciences [16]. Examples include the
deconvolution of anatomical or pathophysiological information
from dynamic contrast-enhanced MRI and analysis of three-
dimensional quantitative structure-activity relationships to predict
the activity of candidate drugs [17–19]. We chose SVD for our
analysis over PCA since PCA first centers the data by subtracting
row or column means. However, the zero value of our matrix was
set to equal an AUC ratio of 1, signifying the absence of an effect
of co-culture on cancer cell proliferation. Thus to shift the zero
value by subtracting means would have sacrificed its intrinsic
meaning.
Decomposition methods are often coupled with cross-validation
strategies to distinguish meaningful components from statistical
noise [20]. The cross-validation strategy we chose to use employs
the EM algorithm for the estimation of missing data [21] as
detailed below.
Let R be the matrix of differences between the co-culture ratio
matrix and 1, such that positive values of R correspond to co-cultures
that stimulated cancer cell proliferation and negative values of R
Cancer-Fibroblast Interaction
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wish to determine an optimal N for R.T od os o ,w eu s em o d e l st h e
complexity of which increase with N to predict the value of each
element of R from all the other elements of R and deem as optimal the
N for which those predictions are maximally accurate.
Specifically, for any matrix S, let Si,j denote the element of S in
the i
th row and j
th column, let Si,j denote S with the element of S in
the i
th row and j
th column missing and let Si,j x ðÞ be Si,j with the
missing element filled in by x. Let AN S ðÞ be the approximation of
S gotten by adding the best N matrices of the singular value
decomposition of S (i.e., those corresponding to the N largest
singular values). In the case of missing data we define AN Si,j ðÞ by
the EM algorithm for the estimation of missing data as follows. Let
S
i,j
1 ~Si,j mean Si,j      
and let
S
i,j
kz1~Si,j AN S
i,j
k
     
i,j
  
:
In our experience, this EM algorithm has always converged as k
increases so we can let
AN Si,j   
~AN lim
k??
S
i,j
k
  
:
Let
ei,j,N~ Ri,j{ AN Ri,j      
i,j
     
     
and let eN be the median of the ei,j,N over all the i and j. The N for
which eN is minimal is deemed to be the optimal N for R.
Gene expression profiling
Confluent plates of fibroblasts (replicating the conditions of co-
culture) or cancer cells in log-phase growth were trypsinized,
centrifuged into pellets, and flash frozen in liquid nitrogen. RNA
was isolated with Qiagen RNeasy kits and profiled using Affymetrix
HG-U133 Plus 2.0 microarrays with standard protocols [22].
Figure 1. Quantitative analysis of cancer-fibroblast cell line interactions. A) Heat map representation of experimentally determined co-
culture ratios for 432 cancer-fibroblast cell line interactions. Red refers to growth-stimulatory interactions and blue to growth-suppressive
interactions. B) Interactions resulting in statistically significant growth stimulation of cancer cells (i.e. the lower bound of the 95% CI for the co-culture
ratio is .1) are shown in red, and interactions resulting in statistically significant growth inhibition of cancer cells (i.e. the upper bound of the 95% CI
for the co-culture ratio is ,1) are shown in blue. The circle indicates the interaction between T47D and AG04351, and the square indicates the
interaction between T47D and AG09877.
doi:10.1371/journal.pone.0006888.g001
Cancer-Fibroblast Interaction
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We first systematically co-cultured twelve human breast,
melanoma, and lung cancer cell lines with thirty-six untrans-
formed, human fibroblast cell lines derived from normal skin and
lung (see Table S1 and Table S2 for details). Each cancer cell line
was tagged with EGFP using lentiviral transduction to enable the
composite quantification of cancer cell proliferation and survival
over fourteen days using a simple plate reader-based assay system.
For each cell line pairing (n=432), which we examined in multiple
replicates over independent experiments, we computed the ratio of
the area under the EGFP curve for cancer cells grown in co-
Figure 2. Cancer cell-fibroblast xenografts. A) EGFP signal from injections of EGFP-expressing T47D cells with AG09877 fibroblasts (5 mice, blue
curve) or AG04351 fibroblasts (4 mice, red curve). Error bars represent standard error of the mean. B) Representative pictures of mice xenografted
with each admixture taken 3 days after injection, with white arrows pointing to injection sites. C) Photomicrographs of a T47D-AG09877 tumor. From
left to right: hematoxylin and eosin staining, GFP fluorescence, and immunohistochemistry for cytokeratin.
doi:10.1371/journal.pone.0006888.g002
Cancer-Fibroblast Interaction
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alone (Figure 1A). We found that fifty-three of 432 cell line
pairings (12%) were growth-stimulatory in absolute terms, defined
by a 95% confidence interval with a lower bound greater than 1
(Figure 1B). In contrast, 176 (41%) were growth-inhibitory and
203 (47%) were null. These data demonstrate that only a minority
of heterotypic cell line pairings yield increased cancer cell growth.
To explore the relevance of these co-cultures in vivo, we next
focused on two specific cancer-fibroblast pairings that displayed
opposing proliferative effects in vitro. Specifically, AG09877
stimulated T47D proliferation, while AG04351 was growth-
inhibitory for this same cancer cell line. Co-injection of T47D
cells and AG09877 fibroblasts subcutaneously in nude mice led to
the formation of small tumors over one week (Figure 2A and 2B).
In contrast, xenografting of these cancer cells with AG04351
fibroblasts did not result in tumor formation. These results
confirmed that opposing effects of different fibroblast populations
on cancer cell growth in vitro could also be observed in vivo.
T47D alone is weakly tumorigenic (data not shown) [23,24], and
the fact that most induced tumors permanently regressed after the
first week suggested that the growth-stimulatory effect of AG09877
fibroblasts was generally insufficient to sustain the prolonged
growth of this cell line in vivo. Notably, however, one animal
actually developed a persistent tumor over the course of six weeks.
Pathologic examination of this single tumor revealed EGFP-
positive cancer cells embedded within a significant desmoplastic
stromal component (Figure 2C). While only a single experiment,
this provocative result suggested that growth-stimulatory fibro-
blasts identified in vitro might be capable of exerting both
transient and more sustained tumorigenic effects on adjacent
cancer cells in vivo.
We next aimed to identify organizational principles underlying
the matrix of co-cultures that might provide insight into the
biological determinants of cancer-fibroblast interaction. System-
atically recreating the cellular interaction matrix using heterotypic
xenografts might have offered further insight into the physiological
relevance of individual pairings, but was not feasible for 432
different interactions. We therefore used a systems-level approach
to characterize and our model in vitro data. To begin with,
cursory inspection of the data in figure 1 revealed that cancer cell
lines could be grouped into those that were predominantly
inhibited (n=3), largely inhibited (n=6), or strongly stimulated
(n=3) by fibroblasts, suggesting that the growth response of a
cancer cell line in a given stromal co-culture was pre-programmed
and independent of the paired fibroblast line (e.g. Figure 3A).
However, only SKBR3 displayed uniform responses across all
fibroblast lines, implicating multiple fibroblast-specific contribu-
tions to cancer cell proliferation. In several cases this fibroblast
contribution was sufficient to override the general predisposition of
the cancer cell line, leading to a growth stimulatory interaction
with an otherwise growth-inhibited cancer cell line or vice-versa
(e.g. Figure 3B). Thus the growth response of cancer cell lines to
stromal co-culture appeared to result from the combination of a
dominant cancer cell-determined contribution and a smaller but
often critically important fibroblast effect.
Although Figure 3B schematically represents a parsimonious
two signal model, the total number of interaction types could not
be readily inferred through qualitative inspection of our dataset.
We therefore used mathematical modeling based on singular value
decomposition to ask whether the complex pattern of growth
stimulation and inhibition we observed across this dataset resulted
from a small, finite number of interaction types between cancer
cells and fibroblasts. Decomposing the matrix of co-culture ratios
into a sum of N component matrices, we used a leave-one-out
cross-validation strategy to define the optimal value for N (Figure 4;
see materials and methods for full details of the model). We found
that the median cross-validation error reached its nadir with N=3,
suggesting that the net co-culture ratio for each cell line pairing
resulted from the sum of interaction values represented by three
distinct component matrices. Matrix A, which accounted for the
majority of error reduction in the model, reflected the varying
responsiveness of different cancer cell lines to generic stromal
signals produced by fibroblasts (Figure 5A). For example, 9 of 12
cancer cell lines generally responded to fibroblasts with slowed
Figure 3. Cancer cell proliferation in co-culture is determined
by properties of both cancer cells and fibroblasts. A) The growth
response of cancer cell lines (circles) to fibroblasts (oblong shapes) is
determined predominantly by the preprogrammed ability of cancer
cells to proliferate in response to generic fibroblast signals (black
arrows) shared in common across all fibroblast lines. Some cancer cell
lines (green) are growth stimulated, while others (yellow) are
unresponsive or growth-inhibited. B) Additional signals produced by
subsets of fibroblasts (red arrows) add complexity by either further
stimulating cancer cell proliferation (upper left panel) or compensating
for the lack of response to generic signals (lower left panel). Although
all signals in this schematic are defined as growth-stimulatory, they may
also be growth-inhibitory thus adding further complexity.
doi:10.1371/journal.pone.0006888.g003
Figure 4. Cross-validation model. Median leave-one-out cross-
validation error when the matrix of co-culture ratios is approximated by
the sum of N component matrices.
doi:10.1371/journal.pone.0006888.g004
Cancer-Fibroblast Interaction
PLoS ONE | www.plosone.org 5 September 2009 | Volume 4 | Issue 9 | e6888Figure 5. Mathematical modeling of cancer-fibroblast interaction. A)–C) Decomposition of the co-culture matrix into 3 component matrices.
When applicable, cancerandfibroblast cell lines aredivided into twogroups (X,green, andY,purple) such thatinteractionswithinthesamegroupmake
growth-stimulatory (i.e. positive) contributions to the estimated co-culture ratio and interactions between opposite groups make growth-inhibitory (i.e.
negative) contributions to the estimated co-culture ratio. P values refer to tissue of origin segregation between X and Y groups. Circles indicate the
interactionbetweenT47DandAG04351,andsquaresindicatetheinteractionbetweenT47DandAG09877.Redreferstogrowth-stimulatory interactions
and blue to growth-suppressive interactions, with intensity corresponding to the strength of the effect and scaled independently within each matrix.
doi:10.1371/journal.pone.0006888.g005
Cancer-Fibroblast Interaction
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cell lines were typically growth-stimulated, as evidenced by BT-
474 and SK-MEL-2.
In contrast, matrix B and matrix C reflected distinct fibroblast
activities that correlated significantly but imperfectly with a given
fibroblast’s tissue of origin (p=6610
25 and p=0.0072 for
matrices B and C respectively) (Figures 5B and 5C). In the space
of each matrix, the fibroblasts were subdivided into two groups
that interacted with distinct subsets of cancer cell lines to promote
cancer cell proliferation (green vs. purple in figure 5). While the
majority of cancer cell lines interacted cooperatively with the
‘‘skin-like’’ fibroblasts in matrix B, a different majority favored the
‘‘lung-like’’ fibroblasts in matrix C. Consequently, we were able to
identify multiple examples in which the same fibroblast-cancer
pairing resulted in positive effects on cancer cell proliferation in
one matrix and negative effects in the other (e.g. T47D-AG07139),
suggesting that fibroblasts could interact with cancer cells in at
least two functionally distinct ways.
Despite the fact that the majority of error reduction in the model
was contributed by matrix A, in some instances the effect size in
matrices B and C in combination was sufficient to override that in
matrix A. In fact, closer analysis revealed that the net effects of
different fibroblasts on cancer cell proliferation could only be
accurately determined by considering the quantitative contributions
of effects from all three matrices. This is illustrated by interactions
between the breast cancer cell line T47D and the two skin fibroblast
cell lines AG09877 and AG04351 (denoted in Figure 1A and
Figure 5A–C by squares and circles, respectively). Matrix A
(Figure 5A) revealed that T47D was generally predisposed to
growth suppression by all fibroblast cell lines. One plausible
biological explanation for this could be the expression of a cell
surface receptor for some cytostatic factor secreted by all fibroblasts.
However, matrix B (Figure 5B) indicated that most skin fibroblast
cell lines had a growth stimulatory activity for T47D, with a few
notableexceptionsincludingAG04351.Intheory,thisactivitycould
be due to the expression by most skin fibroblasts of a specific
mitogenicgrowth factor. In contrast, matrixC (Figure 5C)indicated
that most skin fibroblast cell lines also had a second distinct growth
inhibitory activity for T47D, with the important exception of
AG09877 and several others. This activity could plausibly be
attributed to the secretion by most skin fibroblasts of a specific
growth inhibitory cytokine. Thus AG09877, by expressing the
growth-stimulatory activity and lacking the growth inhibitory
activity, made two functionally distinct growth-stimulatory contri-
butions to T47D growth that were sufficient in combination to
override the general predisposition of T47D to fibroblast-mediated
growth suppression. In contrast, AG04351 only made growth
suppressive contributions with respect to both fibroblast activities.
Table 1. Gene set enrichment analysis of skin vs. lung fibroblasts.
Gene set name Brief description (Pubmed ID)
FDR q-value
for
enrichment
in skin
fibroblasts
FDR q-value
rank for
enrichment
in skin
fibroblasts
FDR q-value
for
enrichment
in Group X
of matrix B
FDR q-value
rank for
enrichment
in Group X
of matrix B
FDR q-value
for
enrichment
in Group X
of matrix C
FDR q-value
rank for
enrichment
in Group X
of matrix C
HTERT_DN Downregulated in hTERT-immortalized
fibroblasts vs. non-immortalized controls
(12702554)
0.07 1 0.88 520 1.00 510
EMT_UP Up-regulated during the TGFbeta-induced
epithelial-to-mesenchymal transition (EMT) of
Ras-transformed mouse mammary epithelial
(EpH4) cells (EMT is representative of late-stage
tumor progression and metastasis) (14562044)
0.15 2 0.30 1 0.91 430
JECHLINGER_EMT_UP Genes upregulated for epithelial plasticity
in tumor progression (14562044)
0.16 3 0.31 2 0.86 377
CIS_XPC_DN Reduced expression in XPC-defective
fibroblasts, compared to normal fibroblasts,
following treatment with cisplatin (15107491)
0.18 4 0.77 28 0.86 374
CMV_24HRS_DN Downregulated at 24 hrs following infection
of primary human foreskin fibroblasts with
CMV (9826724)
0.19 5 0.39 6 0.99 476
TSADAC_RKOEXP_UP Genes with some basal expression and
partially-methylated promoters, upregulated
by the combination of TSA and DAC in RKO
cells (11992124)
0.20 6 0.85 476 0.79 94
IDX_TSA_DN_CLUSTER5 Strongly down-regulated at 2–96 hours during
differentiation of 3T3-L1 fibroblasts into
adipocytes with IDX (insulin, dexamethasone
and isobutylxanthine), vs. fibroblasts treated
with IDX + TSA to prevent differentiation
(cluster 5) (15033539)
0.21 7 0.32 3 1.00 510
FALT_BCLL_DN Genes downregulated in VH3-21+ B-CLL
(15817677)
0.21 8 0.81 91 0.87 399
CROMER_HYPOPHARYNGEAL
_MET_VS_NON_UP
Genes increased in metastatic hypopharyngeal
cancer tumours (14676830)
0.23 9 0.80 64 0.82 214
Nine gene sets enriched in skin vs. lung fibroblasts with corresponding false discovery rate (FDRs) q values and ranks. Also included are the FDR q values and ranks for
each of these gene sets in the group X vs. Y distinction from matrices B and C of Figure 5.
doi:10.1371/journal.pone.0006888.t001
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activities, we isolated RNA from 36 fibroblast cell line monocul-
tures and performed microarray-based gene expression profiling
using Affymetrix gene chips. We first identified genes that were
differentially expressed between skin and lung fibroblasts, between
groups X and Y in matrix B, and between groups X and Y in
matrix C. We then used gene set enrichment analysis (GSEA) [25]
to identify gene sets enriched within each comparison. Using a
false discovery rate (FDR) threshold of 0.25, we identified nine
gene sets enriched in the skin vs. lung fibroblast distinction,
including two that characterize the epithelial-to-mesenchymal
transition (EMT) phenotype (Table 1) [26]. Although associated
with higher FDRs, both sets were also enriched in the Bx (skin-like)
vs. By (lung-like) distinction. In contrast, no gene sets were flagged
in the Cx (skin-like) vs. Cy (lung-like) distinction, suggesting that
this fibroblast activity may either reflect transcriptional differences
only induced within the context of co-culture or non-transcrip-
tional differences that could not be easily detected using
microarray-based transcriptional profiling.
EMT describes a coordinated program of cellular phenotypes
increasingly recognized as crucial to the metastasis of carcinoma
cells. These phenotypes include loss of epithelial cell polarity,
increased cellular migration, and invasion into surrounding tissues
[27]. Moreover, recent evidence indicates that EMT programs also
regulate mesenchymal cell functions including angiogenesis [28].
Furthermore, the transcription factor Snail, a master regulator of
EMT, is expressed in activated fibroblasts within healing wounds
and at the tumor-stromal interface [29]. Our data thus suggested
that EMT programs are preferentially expressed by many skin
fibroblasts, perhaps serving as the molecular basis for one of the
fibroblast activities (Type B) described by our quantitative model.
Closer inspection of the two EMT gene sets reveals that many of
the genes driving the enrichment in skin fibroblasts (i.e. the core
enriched genes) are cell surface and secreted molecules that have
been implicated in stromal contributions to tumor progression
(Figure 6). For example, matrix metalloproteinases and cathepsins
including MMP-2, MMP-12, and cathepsin Z are up-regulated in
tumor stroma and promote cancer cell proliferation, migration,
and invasion by degrading basement membranes and exposing
cryptic migratory and growth signals [30]. Tenascin C is a
matricellular protein that stimulates cancer cell proliferation and
angiogenesis [31]. N-cadherin (CDH2) is expressed in the
filopodia of myofibroblasts that migrate toward malignant cancer
cells in a transforming growth factor beta-dependent manner [32].
SPARC (secreted protein acidic and rich in cysteine) is another
stromal matrix protein that increases cancer cell invasion and that
has been inversely correlated with survival in patients with
pancreatic cancer [33,34]. Stromal PDGFRB regulates interstitial
fluid pressures and drug uptake within tumors [35]. Thus the same
genes that regulate EMT in epithelial cancer cells also regulate
functional contributions to malignant progression from the tumor
stroma. Enriched expression of these genes in skin fibroblasts
suggests tissue-specific preprogramming of mesenchymal popula-
tions for tumor stromal functionality.
Fibroblasts therefore appeared to display at least two distinct
effects on the proliferative response of cancer cells in co-culture.
Figure 6. Enrichment of EMT genes in skin vs. lung fibroblasts. Heat map (right) and enrichment plot (left) for the EMT gene set from GSEA
analysis of skin vs. lung fibroblasts [26].
doi:10.1371/journal.pone.0006888.g006
Cancer-Fibroblast Interaction
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activities and the general responsiveness of cancer cells to
fibroblast signals largely determined the co-culture ratio for a
particular cell line pairing. These independent fibroblast effects
can apparently co-exist within individual fibroblast populations,
functioning either cooperatively or at cross-purposes with respect
to cancer cell growth. Intriguingly, our analysis suggests that both
activities segregate fibroblasts largely according to tissue of origin.
Moreover, microarray profiling indicated that one of these
activities might reflect differential expression of a coordinated
transcriptional program associated with activated mesenchymal
cells. Further work will be required to fully characterize the
molecular basis of each fibroblast activity and to evaluate the
relevance of our findings to cancer-fibroblast interaction in real
tumors.
This work was limited by the nature of the cell populations
examined, insofar as established cancer cell lines and normal tissue
fibroblasts may not completely phenocopy those cell populations
that exist within an evolving human tumor. Additional studies with
larger or more varied fibroblast panels might also identify new and
different patterns of activity. Furthermore, these experiments
included only 12 cancer cell lines. Experiments with a larger and
more diverse cancer cell line panel may eventually reveal
additional correlations between cancer cell tissue of origin or
molecular subtype and growth response in co-culture. Finally, our
SVD-based model was predicated on specific assumptions,
including the supposition that serial deconvolutions of a matrix
each account for maximum residual variability. This assumption
may not always be accurate [36], and other algorithmic
approaches may ultimately prove superior for modeling cell-cell
interaction. However, this study offers a proof of principle that
systems-level modeling may be useful to begin defining the
organizational principles that govern cell-cell interaction. We
anticipate that similar approaches applied to other cell types may
be useful for studying heterotypic cell interaction both in cancer
and other contexts.
Gene expression data have been deposited in NCBI’s Gene
Expression Omnibus [37] and are accessible through GEO Series
accession number GSE17032.
Supporting Information
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